<--Back to project organisation page

Work package 2

Within the general objective of screening for drug candidates targeting aberrant molecular signaling in protein phosphorylation pathways, WP2 is devoted to screening and profiling of compound libraries as basis for rational drug discovery.

Groups in WP 2:
 
Université de Genève
Laboratoire de chimie thérapeutique
Section de pharmacie
Prof. Leonardo Scapozza
 
The Hebrew University of Jerusalem
The Alexander Silberman Institute of Life Sciences
Department of Biological Chemistry
Unit of Cellular Signalling
Prof. Alexander Levitzki
 
University of Innsbruck
Institute of Pharmacy
Computer-Aided Molecular Design Group
    Prof. Thierry Langer
 
  C3Biotech
    Dr. Paul Pechan
 
  Inte:Ligand GmbH
Software Development Unit
    Dr. Gerhard Wolber